IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Mankind Pharma IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 4326.36 Cr. The company is based in New Delhi and caters to Pharmaceutical sector. Axis Capital , Iifl Securities , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Mankind Pharma IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th September 2022.
Mankind Pharma IPO open date is 25th April 2023 and close date is 27th April 2023. IPO Allotment Date is 3rd May 2023 and Listing date is 9th May 2023.
IPO
Size:
₹ 4326.36 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Axis Capital
IPO by BRLM so far:
161
City:
New Delhi
IPO so far:
123
Revenue (annualised):
₹
9037.09
cr. 
PE
Ratio:
0.00x
Average Sector PE Ratio: 25.12x
Mankind Pharma IPO size is ₹ 4326.36 Cr. with IPO price of ₹ 1080.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Capital Limited is the book-running lead manager of the Mankind Pharma IPO. Kfin Technologies Limited is the Registrar for Mankind Pharma IPO.
Mankind Pharma IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Mankind Pharma IPO, based in New Delhi, operates in the Pharmaceutical sector with a focus on pharmaceutical products with a major focus on domestic markets. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Mankind Pharma IPO size is ₹ 4326.36 Cr. with fresh issue size of ₹ 4326.36 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Mankind Pharma IPO is expected to be 3rd May 2023, after the finalization of basis of allotment. Investors can check Mankind Pharma IPO allotment status on the registrars website, Kfin Technologies Limited . Mankind Pharma IPO refund dates are 4th May 2023.
Mankind Pharma IPO is expected to be listed on 9th May 2023.
The upper price band for the Mankind Pharma IPO is set at ₹ 1080.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Mankind Pharma IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Mankind Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 27th April 2023. After submission, funds are blocked until the basis of allotment of Mankind Pharma IPO is finalised.
The merchant banker for Mankind Pharma IPO is Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited . Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Mankind Pharma IPO RHP for further details.
The registrar for Mankind Pharma IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Mankind Pharma IPO through their official website or helpline.
Mankind Pharma IPO was subscribed 15.32 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 4326.36 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Axis Capital
IPO by BRLM so far:
161
City:
New Delhi
IPO so far:
123
Revenue (annualised):
₹ 8.00 cr.
PE
Ratio:
0.00x
Average Sector PE Ratio: 25.12x
Mankind Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Mankind Pharma Financial Review Page
Merchant Banker(s) of Mankind Pharma IPO: Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Mankind Pharma IPO subscription was 15.32 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Mankind Pharma IPO listed at a listing price of 1424.05 against the offer price of 1080.00.
The current market price of Mankind Pharma is 2390.00.
Why Us?
